Updated
Updated · BBC.com · Jul 24
Jackie Maybin Launches 3-Year Program to Cut Heavy Menstrual Bleeding Delays to 5 Months
Updated
Updated · BBC.com · Jul 24

Jackie Maybin Launches 3-Year Program to Cut Heavy Menstrual Bleeding Delays to 5 Months

1 articles · Updated · BBC.com · Jul 24

Summary

  • A 13-researcher initiative called The Missed Vital Sign aims to shrink the average global delay in diagnosing and treating heavy menstrual bleeding from five years to five months over the next three years.
  • Maybin says the push targets a condition long minimized despite affecting an estimated 10% to 30% of reproductive-aged women—and possibly as many as half—while often causing iron deficiency, anaemia and major disruption to daily life.
  • Researchers plan to improve detection with menstrual-fluid biomarkers, smart sensors in period products and smartphone or wearable tools that flag bleeding severity and iron depletion risk.
  • The program also seeks better treatments for bleeding driven by fibroids, endometriosis, blood disorders and other conditions, in a field Maybin says remains badly under-researched compared with male reproductive health.
  • The broader stakes extend beyond clinics: adolescents with heavy bleeding miss up to nine school days a year in the UK, and affected women lose an average 3.6 weeks of work annually.

Insights

If heavy menstrual bleeding affects up to one in three women, why are targeted treatments still so limited?
Could a smartphone or menstrual-fluid test cut heavy bleeding diagnosis from five years to five months?
Why are millions told heavy periods are normal when the bleeding may signal fibroids, anaemia, or cancer?